• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 作为 T 细胞急性淋巴细胞白血病的预后和诊断标志物。

MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia.

机构信息

Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland.

Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.

出版信息

Int J Mol Sci. 2021 May 18;22(10):5317. doi: 10.3390/ijms22105317.

DOI:10.3390/ijms22105317
PMID:34070107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8158355/
Abstract

T cell acute lymphoblastic leukemia (T-ALL) is a biologically and genetically heterogeneous disease with a poor prognosis overall and several subtypes. The neoplastic transformation takes place through the accumulation of numerous genetic and epigenetic abnormalities. There are only a few prognostic factors in comparison to B cell precursor acute lymphoblastic leukemia, which is characterized by a lower variability and more homogeneous course. The microarray and next-generation sequencing (NGS) technologies exploring the coding and non-coding part of the genome allow us to reveal the complexity of the genomic and transcriptomic background of T-ALL. miRNAs are a class of non-coding RNAs that are involved in the regulation of cellular functions: cell proliferations, apoptosis, migrations, and many other processes. No miRNA has become a significant prognostic and diagnostic factor in T-ALL to date; therefore, this topic of investigation is extremely important, and T-ALL is the subject of intensive research among scientists. The altered expression of many genes in T-ALL might also be caused by wide miRNA dysregulation. The following review focuses on summarizing and characterizing the microRNAs of pediatric patients with T-ALL diagnosis and their potential future use as predictive factors.

摘要

T 细胞急性淋巴细胞白血病(T-ALL)是一种生物学和遗传学上具有异质性的疾病,总体预后较差,有几个亚型。肿瘤的转化是通过积累大量的遗传和表观遗传异常发生的。与 B 细胞前体急性淋巴细胞白血病相比,T-ALL 的预后因素较少,后者的变异性较低,病程更具同质性。探索基因组和转录组背景的微阵列和下一代测序(NGS)技术可以揭示 T-ALL 的基因组和转录组背景的复杂性。miRNAs 是一类非编码 RNA,参与细胞功能的调节:细胞增殖、凋亡、迁移和许多其他过程。迄今为止,还没有 miRNA 成为 T-ALL 的重要预后和诊断因素;因此,这个研究课题非常重要,T-ALL 是科学家们深入研究的主题。T-ALL 中许多基因的表达改变也可能是由广泛的 miRNA 失调引起的。以下综述重点总结和描述了儿科 T-ALL 患者的 microRNAs 及其作为预测因子的潜在未来用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12a8/8158355/c4adb7a130b0/ijms-22-05317-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12a8/8158355/dd0e587d5f72/ijms-22-05317-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12a8/8158355/c4adb7a130b0/ijms-22-05317-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12a8/8158355/dd0e587d5f72/ijms-22-05317-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12a8/8158355/c4adb7a130b0/ijms-22-05317-g002.jpg

相似文献

1
MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia.微小 RNA 作为 T 细胞急性淋巴细胞白血病的预后和诊断标志物。
Int J Mol Sci. 2021 May 18;22(10):5317. doi: 10.3390/ijms22105317.
2
A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL).急性 T 细胞淋巴细胞白血病(T-ALL)中协同的 microRNA-肿瘤抑制基因网络。
Nat Genet. 2011 Jun 5;43(7):673-8. doi: 10.1038/ng.858.
3
MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.微小 RNA 可描绘儿科急性淋巴细胞白血病的遗传多样性和耐药性。
Haematologica. 2011 May;96(5):703-11. doi: 10.3324/haematol.2010.026138. Epub 2011 Jan 17.
4
T-cell acute lymphoblastic leukemia from miRNA perspective: Basic concepts, experimental approaches, and potential biomarkers.从 miRNA 角度看 T 细胞急性淋巴细胞白血病:基本概念、实验方法和潜在的生物标志物。
Blood Rev. 2018 Nov;32(6):457-472. doi: 10.1016/j.blre.2018.04.003. Epub 2018 Apr 12.
5
Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma.miRNA - 17和miRNA - 19的上调与T细胞淋巴母细胞淋巴瘤患者的不良预后相关。
Exp Mol Pathol. 2015 Oct;99(2):297-302. doi: 10.1016/j.yexmp.2015.07.012. Epub 2015 Jul 29.
6
MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemia.微小RNA-128-3p是一种新型致癌性微小RNA,在T细胞急性淋巴细胞白血病中靶向PHF6。
Haematologica. 2014 Aug;99(8):1326-33. doi: 10.3324/haematol.2013.099515. Epub 2014 Jun 3.
7
Prognostic miRNA classifiers in t cell acute lymphoblastic leukemia: Study protocol for a systematic review and meta-analysis of observational clinical studies.T细胞急性淋巴细胞白血病中的预后性miRNA分类器:观察性临床研究的系统评价与荟萃分析研究方案
Medicine (Baltimore). 2019 Mar;98(9):e14569. doi: 10.1097/MD.0000000000014569.
8
Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.通过整合分析微小RNA和信使核糖核酸表达谱对B系和T系急性淋巴细胞白血病进行特征描述
Genes Chromosomes Cancer. 2009 Dec;48(12):1069-82. doi: 10.1002/gcc.20709.
9
T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases.与儿童病例相比,婴儿T细胞急性淋巴细胞白血病具有独特的遗传和表观遗传特征。
Genes Chromosomes Cancer. 2017 Feb;56(2):159-167. doi: 10.1002/gcc.22423. Epub 2016 Oct 26.
10
MicroRNA-211 attenuates cell proliferation in T-cell lymphoblastic lymphoma through targeting TCF12.微小RNA-211通过靶向TCF12抑制T细胞淋巴母细胞淋巴瘤中的细胞增殖。
Leuk Res. 2021 Nov;110:106653. doi: 10.1016/j.leukres.2021.106653. Epub 2021 Jun 29.

引用本文的文献

1
The miRNA Landscape of Leukemia - Cellular Actions to Therapy through Molecular Mechanisms.白血病的miRNA全景——通过分子机制实现细胞作用以进行治疗
Cell Biochem Biophys. 2025 Jul 18. doi: 10.1007/s12013-025-01820-4.
2
MicroRNA-34a-5p induces cell cycle arrest and leads to spermatogenesis failure by targeting CDC25A.微小RNA-34a-5p通过靶向细胞周期蛋白磷酸酶25A(CDC25A)诱导细胞周期停滞并导致精子发生失败。
Cell Mol Life Sci. 2025 May 26;82(1):212. doi: 10.1007/s00018-025-05738-1.
3
Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1.

本文引用的文献

1
Diagnostic, prognostic and predictive values of miR-100 and miR-210 in pediatric acute lymphoblastic Leukemia.miR-100 和 miR-210 在小儿急性淋巴细胞白血病中的诊断、预后和预测价值。
Hematology. 2020 Dec;25(1):405-413. doi: 10.1080/16078454.2020.1843753.
2
[Expression and Clinical Significance of MiR-146a and MiR-221 in Childhood Acute T Lymphoblastic Leukemia].[微小RNA-146a和微小RNA-221在儿童急性T淋巴细胞白血病中的表达及临床意义]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Apr;28(2):436-441. doi: 10.19746/j.cnki.issn.1009-2137.2020.02.013.
3
Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
通过同时抑制NOTCH1和SF3B1提高紫杉醇在慢性淋巴细胞白血病中的治疗效果。
Cancer Cell Int. 2025 Mar 19;25(1):104. doi: 10.1186/s12935-025-03702-4.
4
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies.免疫检查点与非编码RNA:血液系统恶性肿瘤的开创性免疫治疗方法
Cancer Cell Int. 2024 Dec 19;24(1):410. doi: 10.1186/s12935-024-03596-8.
5
Notch Inhibitors and BH3 Mimetics in T-Cell Acute Lymphoblastic Leukemia.Notch抑制剂与BH3模拟物在T细胞急性淋巴细胞白血病中的应用
Int J Mol Sci. 2024 Nov 29;25(23):12839. doi: 10.3390/ijms252312839.
6
Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL.Notch3 调控的 microRNAs 损害了 CXCR4 依赖的胸腺细胞成熟,从而允许 T-ALL 的维持和进展。
Oncogene. 2024 Aug;43(34):2535-2547. doi: 10.1038/s41388-024-03079-0. Epub 2024 Jun 21.
7
The impact of COVID-19 on microRNA and CD marker expression in AML patients.COVID-19 对 AML 患者中 microRNA 和 CD 标志物表达的影响。
Sci Rep. 2024 Jun 20;14(1):14251. doi: 10.1038/s41598-024-64775-1.
8
MiRNAs in Hematopoiesis and Acute Lymphoblastic Leukemia.miRNAs 在造血和急性淋巴细胞白血病中的作用。
Int J Mol Sci. 2023 Mar 12;24(6):5436. doi: 10.3390/ijms24065436.
9
Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical Translation.微小 RNA 与肿瘤发生的关系,重点关注血液系统恶性肿瘤及其临床转化。
Int J Mol Sci. 2022 May 23;23(10):5838. doi: 10.3390/ijms23105838.
10
miRNAs in Lymphocytic Leukaemias-The miRror of Drug Resistance.淋巴细胞白血病中的 miRNAs-耐药的 miRror。
Int J Mol Sci. 2022 Apr 22;23(9):4657. doi: 10.3390/ijms23094657.
BAALC 和 miR-326 表达水平的同时变化:儿童 ALL 的新型预后生物标志物。
Jpn J Clin Oncol. 2020 Jun 10;50(6):671-678. doi: 10.1093/jjco/hyaa025.
4
LeukmiR: a database for miRNAs and their targets in acute lymphoblastic leukemia.LeukmiR:急性淋巴细胞白血病中的 miRNA 及其靶标数据库。
Database (Oxford). 2020 Jan 1;2020. doi: 10.1093/database/baz151.
5
Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis.极光激酶 B 通过直接磷酸化和稳定 MYC 促进 T 细胞白血病发生。
Cancer Cell. 2020 Feb 10;37(2):200-215.e5. doi: 10.1016/j.ccell.2020.01.001.
6
Role of epigenetic in leukemia: From mechanism to therapy.表观遗传学在白血病中的作用:从机制到治疗。
Chem Biol Interact. 2020 Feb 1;317:108963. doi: 10.1016/j.cbi.2020.108963. Epub 2020 Jan 21.
7
miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer.微小RNA-451:一种新型癌症生物标志物及潜在治疗靶点
Onco Targets Ther. 2019 Dec 16;12:11069-11082. doi: 10.2147/OTT.S230963. eCollection 2019.
8
MicroRNAs and their involvement in T-ALL: A brief overview.微小RNA及其在T细胞急性淋巴细胞白血病中的作用:简要概述
Adv Biol Regul. 2019 Dec;74:100650. doi: 10.1016/j.jbior.2019.100650. Epub 2019 Sep 5.
9
Prognostic Role of miR-221 and miR-222 Expression in Cancer Patients: A Systematic Review and Meta-Analysis.miR-221和miR-222表达在癌症患者中的预后作用:一项系统评价和荟萃分析
Cancers (Basel). 2019 Jul 11;11(7):970. doi: 10.3390/cancers11070970.
10
Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia.克服 T 细胞急性淋巴细胞白血病耐药机制的策略。
Int J Mol Sci. 2019 Jun 20;20(12):3021. doi: 10.3390/ijms20123021.